Mid
R
RGNXAI Stock Diagnostic Report
Regenxbio outlines cash runway into Q4 2027 as RGX-202 targets module 1 BLA filing in Q3 2026
Regenxbio has secured sufficient cash reserves through the fourth quarter of 2027 and announced plans to submit a BLA application for RGX-202.
View Source Article ↗AI CATALYST SCORE75 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time